Evelyne Crapez

Suggest Changes
Learn More
e14002 Background: The raf kinase inhibitor S is the lead compound in a series of raf signalling pathway inhibitors that could inhibit cell growth and proliferation of pts in KRAS mt pts. The aim of(More)
In oncology, simultaneous inhibition of epidermal growth factor receptor (EGFR) and HER2 by monoclonal antibodies (mAbs) is an efficient therapeutic strategy but the underlying mechanisms are not(More)
  • 1